Conference abstract · 16 Oct 2023
Conference abstractPublished 27 Jul 2017
Untitled abstract
Western University of Health Sciences, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Although more than 50% of anticancer drugs are originally derived from natural products, the use of herbal products as a systemic chemotherapeutic agent is not an accepted practice in Western countries since these products are not approved by regulatory agencies due to lack of definitive clinical efficacy studies. However, there is increasing evidence that a number of herbal products especially in combination with established anticancer drugs can significantly re-sensitize certain anticancer drugs via different mechanisms. Such activity offers new therapeutic potential of their use in cancer chemotherapy, especially for resistant cancer, which is responsible for the high cancer mortality globally. Various examples of herbal product that can exert different cytotoxic effects leading to enhanced activity when combined with conventional anticancer agents will be presented and the advantage of development of such combination products for therapeutic use will be discussed
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 12 Apr 2023
Untitled abstract
Conference abstract · 24 Aug 2021
Untitled abstract
Conference abstract · 24 May 2021
Untitled abstract
Conference abstract · 24 May 2021
Untitled abstract
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Moses S S Chow”
